Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review.
about
Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Significant benefit of Nivolum ...... report and literature review.
@en
Significant benefit of Nivolum ...... report and literature review.
@nl
type
label
Significant benefit of Nivolum ...... report and literature review.
@en
Significant benefit of Nivolum ...... report and literature review.
@nl
prefLabel
Significant benefit of Nivolum ...... report and literature review.
@en
Significant benefit of Nivolum ...... report and literature review.
@nl
P2093
P2860
P356
P1433
P1476
Significant benefit of Nivolum ...... report and literature review.
@en
P2093
Jiayun Zou
Lina Zhang
Mingfang Zhao
Mingxia Ma
Xiujuan Qu
Yishan Chen
P2860
P304
96453-96459
P356
10.18632/ONCOTARGET.19089
P407
P577
2017-07-07T00:00:00Z